Mar 6, 2020 9:00 am EST Cerecor Announces Appointment of H. Jeffery Wilkins MD as Chief Development Officer
Aug 21, 2019 6:30 am EDT Cerecor Receives Fast Track Designation from FDA for CERC-802 for the Treatment of Mannose-Phosphate Isomerase Deficiency
